A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer

Overview of attention for article published in Redox Biology, October 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#3 of 2,687)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 24 news outlets
blogs: 4 blogs
twitter: 301 X users
facebook: 2 Facebook pages

reddit: 6 Redditors
video: 1 YouTube creator
bluesky: 10 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 10 Bluesky posts from 10 Bluesky users, with an upper bound of 11,887 followers.

Adding high dose IV Vit C (75g three times per wk) to traditional chemo doubled survival time in Metastatic Pancreatic cancer www.sciencedirect.com/science/arti...

Exciting Phase II results on high-dose vitamin C in PDAC! 🧪📈 tinyurl.com/msswxk6p ☣️ Potential survival benefits & better chemo tolerance ⛔️ Methodological limitations exist warranting some caution ✅️ A Phase III trial is crucial to confirm effective…

Vitamin C + chemo doubled cancer survival compared to chemo alone.

Adding vitamin C to gemcitabine-paclitaxel doubles survival in pancreatic cancer. www.sciencedirect.com/science/arti... #Vitamin C and #pancreatic_cancer! A clinical trial in "Redox Biology" 🤨 Anyone can help with possible flaws in this study? It is…

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 6 additional Bluesky posts.